RSNA 2011 

Abstract Archives of the RSNA, 2011


MSVI21-05

Safety and Effectiveness of Uterine Fibroid Embolization for Large-sized Clinically Measured Uterine Fibroids

Scientific Formal (Paper) Presentations

Presented on November 28, 2011
Presented as part of MSVI21: Interventional Radiology Series: Interventions in the Female Pelvis

Participants

Vijay Ramalingam MD, Presenter: Nothing to Disclose
Nii-Kabu Kabutey MD, Abstract Co-Author: Nothing to Disclose
Tatianie Jackson MD, Abstract Co-Author: Nothing to Disclose
Malik Dawoud MD, Abstract Co-Author: Nothing to Disclose
Steven Deso MD, MS, Abstract Co-Author: Nothing to Disclose
Steven Baer MD, Abstract Co-Author: Nothing to Disclose
Ducksoo Kim MD, Abstract Co-Author: Nothing to Disclose

PURPOSE

To demonstrate that uterine fibroid embolization (UFE) is safe and effective in patient with large-sized uterine fibroids measuring 15-25 weeks on clinical palpation. UFE can be performed with minimal complications and can provide a significant reduction in symptomatology among this patient population.

METHOD AND MATERIALS

A retrospective clinical database analysis of 1257 patients collected over a 13-year time period. Two hundred eighty-two patients with clinically palpable large-sized uterine fibroids measuring 15-25 weeks underwent UFE. All of the patients were examined and referred by their primary care physicians. A detailed assessment of patients demographic information and clinical outcomes were collected and analyzed

RESULTS

Two hundred eighty-two patients (22.4%) of the1257 with large, clinically palpable uterine fibroids (15 to 25 weeks) underwent bilateral uterine artery embolization. Prior to treatment 236 patients were experiencing multiple symptoms while at 3 month follow-up 11 patients were recorded as continuing to have multiple symptoms. The procedural complication rate was (0.02%). Prior to UFE, 55 patients (19.5%) had attempted alternative treatment modalities.

CONCLUSION

UFE has a low procedural complication rate and effectively reduces patient symptomatology patient’s among patients with clinically uterine fibroids measuring 15-25 weeks in size.

CLINICAL RELEVANCE/APPLICATION

This study aims to show that uterine fibroid embolization is safe for large sized clinically measured uterine fibroids

Cite This Abstract

Ramalingam, V, Kabutey, N, Jackson, T, Dawoud, M, Deso, S, Baer, S, Kim, D, Safety and Effectiveness of Uterine Fibroid Embolization for Large-sized Clinically Measured Uterine Fibroids.  Radiological Society of North America 2011 Scientific Assembly and Annual Meeting, November 26 - December 2, 2011 ,Chicago IL. http://archive.rsna.org/2011/11008514.html